| Literature DB >> 27548151 |
Vinicius C Soeiro1, Karoline R T Melo2, Monique G C F Alves3, Mayara J C Medeiros4, Maria L P M Grilo5, Jailma Almeida-Lima6, Daniel L Pontes7, Leandro S Costa8,9, Hugo A O Rocha10.
Abstract
Dextrans (α-d-glucans) extracted from Leuconostoc mesenteroides, with molecular weights (MW) of 10 (D10), 40 (D40) and 147 (D147) kDa, were evaluated as antioxidant, anticoagulant and immunomodulatory drugs for the first time. None presented anticoagulant activity. As for the antioxidant and immunomodulatory tests, a specific test showed an increase in the dextran activity that was proportional to the increase in molecular weight. In a different assay, however, activity decreased or showed no correlation to the MW. As an example, the reducing power assay showed that D147 was twice as potent as other dextrans. On the other hand, all three samples showed similar activity (50%) when it came to scavenging the OH radical, whereas only the D10 sample showed sharp activity (50%) when it came to scavenging the superoxide ion. D40 was the single dextran that presented with immunomodulatory features since it stimulated the proliferation (~50%) of murine macrophages (RAW 264.7) and decreased the release of nitric oxide (~40%) by the cells, both in the absence and presence of lipopolysaccharides (LPS). In addition, D40 showed a greater scavenging activity (50%) for the hydrogen peroxide, which caused it to also be the more potent dextran when it came to inhibiting lipid peroxidation (70%). These points toward dextrans with a 40 kDa weight as being ideal for antioxidant and immunomodulatory use. However, future studies with the D40 and other similarly 40 kDa dextrans are underway to confirm this hypothesis.Entities:
Keywords: ">d-glucans; 40 kDa dextran; Leuconostoc mesenteroides; antioxidant activity; immunomodulatory activity; α-
Mesh:
Substances:
Year: 2016 PMID: 27548151 PMCID: PMC5000737 DOI: 10.3390/ijms17081340
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Fourier transform infrared spectroscopy (FTIR) spectra of the dextrans. The characteristics signals are in evidence for the regions between 4000 and 400 cm−1.
Chemical composition of the D10, D40 and D147 dextrans.
| Dextrans | Total Sugar (%) | Proteins (%) | Phenolic Compounds (%) | Molar Ratio * (%) | ||
|---|---|---|---|---|---|---|
| Glc | Man | Gal | ||||
| D10 | 91.3 | n.d. | n.d. | 1:0 | 0:0 | 0:0 |
| D40 | 90.5 | n.d. | n.d. | 1:0 | 0:0 | 0:0 |
| D147 | 93.1 | n.d. | n.d. | 1:0 | 0:0 | 0:0 |
Glc: glucose; Man: mannose; Gal: galactose. * Molar ratio obtained by high performance liquid chromatography (HPLC) analyses after acid hydrolysis (HCl 2 M; 2 h; 100 °C). n.d.: Not detectable in the evaluated conditions.
Figure 2Antioxidant activities of D10, D40 and D147. (A) Ferrous chelating; (B) copper chelating; (C) total antioxidant capacity; (D) reducing Power; (E) hydroxyl radical scavenging; (F) inhibiting lipid peroxidation; (G) hydrogen peroxide radical scavenging; and (H) superoxide radical scavenging. Letters a,b,c represent the significant difference between the samples by the simple variance analyses (one-way ANOVA) followed by the Tukey–Kramer (p < 0.05) test.
Figure 3Effect of D10, D40 and D147 in RAW cells: (A) 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) mitochondrial reduction by cells in the presence of glucans; and (B) nitric oxide production by RAW cells in the presence of glucans. Letters a,b represent the significant difference between the various samples according to the simple variation analyses (one-way ANOVA) followed by the Tukey–Kramer (p < 0.05) test. LPS, lipopolysaccharides.
Figure 4Anticoagulant activities of D1, D40 and D147: (A) activated partial thromboplastin time (aPTT); and (B) prothrombin time (PT). Letter a represent non-significant difference between the various samples according to the variation analyses (one-way ANOVA) followed by the Tukey–Kramer (p < 0.05) test.